FindTrial
Sign In

EsoHep - Evaluation of liver function for perioperative risk assessment in patients with esophageal carcinoma

EsoHep - Evaluation of liver function for perioperative risk assessment in patients with esophageal carcinoma - EsoHep

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00019201
Enrollment
40
Registered
2019-12-17
Start date
2020-08-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C15.1 C16.0

Interventions

Group 1: Liver function test via LiMAx, FibroScan, blood test, MultiLiverScan, CT, MRI, macroscopy and biopsy

Sponsors

Universitätsklinikum Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: squamous cell carcinoma of the middle or distal esophagus or adenocarcinoma of the esophagogastric junction Typ I or II with a BMI over 30 neoadjuvant radiochemotherapy or chemotherapy Initial staging uT2-3 Nx M0 Informed patients consent

Exclusion criteria

Exclusion criteria: ASA = IV FEV1 < 1,5 l ECOG = 2 Non-resectable primary tumours

Design outcomes

Primary

MeasureTime frame
Aim is the comparison of the available non-invasive liver function test with the liver biopsy—

Countries

Germany

Contacts

Public ContactDenise Buchner

Universitätsklinikum Köln

denise.buchner@uk-koeln.de+49 221 478 32654

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026